Lipoprotein a is an Independent Risk Factor for Overall Survival in Patients With Pancreatic Cancer: a Propensity Score Matching Analysis
NCT06316466 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 360
Last updated 2024-03-18
Summary
Background: This study aims to assess the prognostic significance of serum lipoprotein (a) \[Lp (a)\] levels on overall survival (OS) and progression free survival (PFS) in individuals diagnosed with pancreatic cancer through the utilization of propensity score matching (PSM).
Methods: A retrospective analysis was conducted on the clinicopathological data of 364 patients diagnosed with pancreatic cancer at the Affiliated Hospital of Qingdao University from January 2019 to December 2022. The cut-off value for Lp (a) was determined based on one-year survival rates after diagnosis. Patients were then categorized into the high and low Lp (a) groups. We applied PSM analysis to minimize selection bias. The study compared OS and PFS between two groups by Kaplan-Meier method and analyzed differences using the log-rank test. Additionally, univariate and multivariate Cox-regression analyses were performed to identify prognostic factors among patients.
Conditions
- Pancreatic Carcinoma; Lipoprotein a; Overall Survival; Prognosis
Interventions
- OTHER
-
Lp(a)
The cut-off value for Lp (a) was determined based on one-year survival rates after diagnosis. Patients were then categorized into the high and low Lp (a) groups.
Sponsors & Collaborators
-
jingxue
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-06-01
- Primary Completion
- 2024-01-30
- Completion
- 2024-03-30
Countries
- China
Study Locations
More Related Trials
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomics Techniques
NCT05088161 ·Status: UNKNOWN
-
Molecular Profile-related Individualized Targeted Therapy in Resected Pancreatic Cancer With High-Risk of Cancer Recurrence
NCT06228599 ·Status: RECRUITING ·Phase: NA
-
Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques
NCT05289895 ·Status: UNKNOWN
-
Analyzing and Solving Exceptional Long-term Survivors in Solid Tumors With Poor Prognosis
NCT06160596 ·Status: RECRUITING
-
Biomarkers Study in Pancreatic Cancer
NCT01666184 ·Status: UNKNOWN
-
Molecular Subtyping for Prognosis Evaluation in Resected Pancreatic Adenocarcinoma
NCT05483257 ·Status: COMPLETED
-
Influence of Metastatic Sites on Survival Outcomes and Predictive Factors for Extended Survival in Metastatic Pancreatic Cancer a Retrospective Study
NCT07086352 ·Status: NOT_YET_RECRUITING
-
Safety and Effectiveness Study of CPI-613 and/or Gemcitabine to Treat Metastatic Pancreatic Cancer
NCT01830322 ·Status: WITHDRAWN ·Phase: PHASE2
-
The Significance and Indications of Surgery for Synchronous Liver Metastatic Pancreatic Cancer
NCT06873178 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy
NCT04466189 ·Status: ENROLLING_BY_INVITATION
-
Pancreatic Disease Burden in Older Adults (1990-2040)
NCT07177599 ·Status: COMPLETED
-
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823 ·Status: ACTIVE_NOT_RECRUITING
-
Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPC
NCT04855331 ·Status: RECRUITING ·Phase: NA
-
Perioperative Therapy for Resectable and Borderline-Resectable Pancreatic Adenocarcinoma With Molecular Correlates
NCT02723331 ·Status: COMPLETED ·Phase: PHASE2
-
Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer
NCT02681601 ·Status: TERMINATED ·Phase: NA
-
A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
NCT01608711 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Irinotecan Liposome Injection-containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
NCT05047991 ·Status: UNKNOWN ·Phase: PHASE2
-
A Study of the Effect of Gemcitabine With Fish Oil in Patients With Advanced Pancreatic Cancer
NCT01019382 ·Status: COMPLETED ·Phase: PHASE2
-
A Clinical Study of BRCA and DNA Damage Repair Genes in Blood Samples of Chinese Pancreatic Cancer Patients
NCT05138302 ·Status: UNKNOWN
-
A Prospective Study of Liquid Biopsy for Pancreatic Cancer Early Detection
NCT06166147 ·Status: RECRUITING
-
Multimodal Therapy Impact on Pancreatic Cancer Survival
NCT06938906 ·Status: ACTIVE_NOT_RECRUITING
-
Pancreatic Cancer With Elevated Serum CA125 Were Compared With Those Who Did Not Receive Neoadjuvant Chemotherapy.
NCT04835064 ·Status: UNKNOWN ·Phase: PHASE3
-
Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer
NCT06538623 ·Status: COMPLETED ·Phase: PHASE2
-
Related Studies of Imaging Features and Prognosis Between Pancreatic Neuroendocrine Tumors and Pancreatic Cancer
NCT04977596 ·Status: COMPLETED
-
A Retrospective Study for Nimotuzumab Plus Postoperative Adjuvant Chemotherapy for Resectable Pancreatic Cancer
NCT06363084 ·Status: COMPLETED